U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C20H29FN2O3
Molecular Weight 364.4543
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FALLYPRIDE

SMILES

COC1=CC(CCCF)=CC(C(=O)NC[C@@H]2CCCN2CC=C)=C1OC

InChI

InChIKey=OABRYNHZQBZDMG-INIZCTEOSA-N
InChI=1S/C20H29FN2O3/c1-4-10-23-11-6-8-16(23)14-22-20(24)17-12-15(7-5-9-21)13-18(25-2)19(17)26-3/h4,12-13,16H,1,5-11,14H2,2-3H3,(H,22,24)/t16-/m0/s1

HIDE SMILES / InChI

Molecular Formula C20H29FN2O3
Molecular Weight 364.4543
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description

Fallypride is a high-affinity antagonist of dopamine D2 and D3 receptors. 18F-radiolabeled fallypride is used as a PET tracer to characterize D2/D3 receptors in the brain.

Approval Year

Targets

Primary TargetPharmacologyConditionPotency
2.1 nM [Ki]
1.6 nM [Ki]

PubMed

Substance Class Chemical
Record UNII
G9FWZ369GX
Record Status Validated (UNII)
Record Version